Literature DB >> 2056117

Induction of IgG antibodies against GD3 ganglioside in rabbits by an anti-idiotypic monoclonal antibody.

P B Chapman1, A N Houghton.   

Abstract

Anti-idiotypic MAb were raised in syngeneic mice against a mouse MAb recognizing GD3 ganglioside (MAb R24). Two anti-idiotypic MAb, designated BEC2 and BEC3, recognized distinct determinants on MAb R24 that mapped near or within the GD3-binding site. New Zealand white rabbits, which express GD3 on normal tissues, were immunized with either BEC2, BEC3, or control MAb FLOPC-21. All rabbits developed high and equivalent titers of antibodies against mouse immunoglobulins. Immunization with BEC2 and BEC3 induced rabbit antibodies expressing R24 idiotype as demonstrated by their ability to inhibit BEC2 binding to R24. Antibodies (IgG and IgM) reacting with GD3 developed in five of eight rabbits immunized with BEC2 but not in rabbits immunized with BEC3 or with control MAb. Serum antibodies against GD3 did not cross-react with other gangliosides. These results show that MAb BEC2 can mimic GD3 ganglioside and can induce antibodies against GD3 ganglioside despite expression of GD3 on normal rabbit tissue.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2056117      PMCID: PMC296019          DOI: 10.1172/JCI115276

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  Light chain variants of an IgG3 anti-GD3 monoclonal antibody and the relationship among avidity, effector functions, tumor targeting, and antitumor activity.

Authors:  P B Chapman; M Lonberg; A N Houghton
Journal:  Cancer Res       Date:  1990-03-01       Impact factor: 12.701

2.  Idiotype-antiidiotype regulation. V. The requirement for immunization with antigen or monoclonal antiidiotypic antibodies for the activation of beta 2 leads to 6 and beta 2 leads to 1 polyfructosan-reactive clones in BALB/c mice treated at birth with minute amounts of anti-A48 idiotype antibodies.

Authors:  L J Rubinstein; B Goldberg; J Hiernaux; K E Stein; C A Bona
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

3.  Towards a network theory of the immune system.

Authors:  N K Jerne
Journal:  Ann Immunol (Paris)       Date:  1974-01

4.  Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2.

Authors:  L D Cahan; R F Irie; R Singh; A Cassidenti; J C Paulson
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

5.  Antibodies to glycosphingolipids in patients with multiple sclerosis and SLE.

Authors:  T Endo; D D Scott; S S Stewart; S K Kundu; D M Marcus
Journal:  J Immunol       Date:  1984-04       Impact factor: 5.422

6.  Ganglioside GM2 as a human tumor antigen (OFA-I-1).

Authors:  T Tai; J C Paulson; L D Cahan; R F Irie
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

7.  Comparative study on ganglioside compositions of various rabbit tissues. Tissue-specificity in ganglioside molecular species of rabbit thymus.

Authors:  M Iwamori; Y Nagai
Journal:  Biochim Biophys Acta       Date:  1981-08-24

8.  Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies.

Authors:  W G Dippold; K O Lloyd; L T Li; H Ikeda; H F Oettgen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

9.  Preparation and properties of antibodies to GD3 and GM1 gangliosides.

Authors:  S K Kundu; D M Marcus; R W Veh
Journal:  J Neurochem       Date:  1980-01       Impact factor: 5.372

10.  Human melanoma antigen AH is an autoantigenic ganglioside related to GD2.

Authors:  T Watanabe; C S Pukel; H Takeyama; K O Lloyd; H Shiku; L T Li; L R Travassos; H F Oettgen; L J Old
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

View more
  13 in total

Review 1.  Clinical utility of autoantibodies in Guillain-Barre syndrome and its variants.

Authors:  J W Terryberry; Y Shoenfeld; J B Peter
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

Review 2.  Biosynthesis and functions of gangliosides: recent advances.

Authors:  K O Lloyd; K Furukawa
Journal:  Glycoconj J       Date:  1998-07       Impact factor: 2.916

3.  Respiratory Homeostasis and Exploitation of the Immune System for Lung Cancer Vaccines.

Authors:  Adam Yagui-Beltrán; Lisa M Coussens; David M Jablons
Journal:  US Oncol       Date:  2009

4.  Murine monoclonal anti-idiotope antibody breaks unresponsiveness and induces a specific antibody response to human melanoma-associated proteoglycan antigen in cynomolgus monkeys.

Authors:  P Chattopadhyay; J Starkey; W J Morrow; S Raychaudhuri
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

5.  Development of a novel therapy for Lipo-oligosaccharide-induced experimental neuritis: use of peptide glycomimics.

Authors:  Seigo Usuki; Kyoji Taguchi; Yi-Hua Gu; Stuart A Thompson; Robert K Yu
Journal:  J Neurochem       Date:  2010-02-01       Impact factor: 5.372

6.  Novel anti-idiotype antibody therapy for lipooligosaccharide-induced experimental autoimmune neuritis: use relevant to Guillain-Barré syndrome.

Authors:  S Usuki; K Taguchi; S A Thompson; P B Chapman; R K Yu
Journal:  J Neurosci Res       Date:  2010-06       Impact factor: 4.164

7.  Mapping effector functions of a monoclonal antibody to GD3 by characterization of a mouse-human chimeric antibody.

Authors:  P B Chapman; S D Gillies; A N Houghton; R M Reilly
Journal:  Cancer Immunol Immunother       Date:  1994-09       Impact factor: 6.968

8.  Racotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides - preclinical and clinical data.

Authors:  Ana M Vázquez; Ana M Hernández; Amparo Macías; Enrique Montero; Daniel E Gómez; Daniel F Alonso; Mariano R Gabri; Roberto E Gómez
Journal:  Front Oncol       Date:  2012-10-23       Impact factor: 6.244

9.  Anti-ganglioside anti-idiotypic vaccination: more than molecular mimicry.

Authors:  Ana M H Vázquez; Nely Rodrèguez-Zhurbenko; Ana M V López
Journal:  Front Oncol       Date:  2012-11-20       Impact factor: 6.244

10.  P3 mAb: An Immunogenic Anti-NeuGcGM3 Antibody with Unusual Immunoregulatory Properties.

Authors:  Darel Martínez; Nely Rodríguez; Tania Griñán; Teresa Rondón; Ana María Vázquez; Rolando Pérez; Ana María Hernández
Journal:  Front Immunol       Date:  2012-04-26       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.